00174-1/asset/78f65028-19d3-4307-9d22-cec15077f8ce/main.assets/gr3_lrg.jpg)
semaglutide efficacy and safety of once-weekly 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial Semaglutide Approved for Type 2
Description
Lancet lond
Sara Klockars: Well, this is a bit nuanced and complex due to some limited robust safety data
How tirzepatide differs from other GLP-1 medications Worth noting: tirzepatide has a greater impact on oral contraceptive absorption than other GLP-1 receptor agonists like semaglutide
It adjusts its touchpoints based on user data - if someone is showing high compliance, it minimizes notifications
As the medication leaves your body, your appetite and cravings come back
